Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:45 AM
Ignite Modification Date:
2025-12-25 @ 4:45 AM
NCT ID:
NCT04874818
Eligibility Criteria:
Inclusion Criteria:
* a microbiologically proven SARS-CoV2 infection
* More than 50 years of age;
* Ability to provide written informed consent.
Exclusion Criteria:
* Contra-indication for PET: Pregnancy, Breast-feeding, Severe claustrophobia.
* Contra-indication for administration of iodine-containing contrast agents
* Other serious illness, e.g. history of malignancies or auto-immune disorders
* Known pre-existing lymphopenia from an unrelated other medical condition
* Estimated creatinine clearance ≤ 30 mL/min according to the Cockcroft-Gault formula (or local institutional standard method) OR oligo-uric patients (\<400 mL/24hr)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT04874818
Study Brief:
Protocol Section:
NCT04874818